Belvedere Trading’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.99K Buy
+13,300
New +$99.5K ﹤0.01% 971
2024
Q2
Sell
-410
Closed -$59.4K 719
2024
Q1
$59.4K Buy
+410
New +$34.6K ﹤0.01% 493
2023
Q3
Sell
-290
Closed -$18.3K 693
2023
Q2
$18.3K Buy
+290
New +$17.6K ﹤0.01% 669

Other funds holding CDLX

Belvedere Trading's CDLX Position: Q2 2026 in Review

Belvedere Trading opened a new position in Cardlytics (CDLX) in Q2 2026: 761 shares worth $3.42K. The stake represents ﹤0.01% of the portfolio and ranks #999 among its holdings. This is a return to the name: Belvedere Trading previously reported a position in CDLX as recently as Q1 2024.

Belvedere Trading first reported a position in CDLX in Q2 2023 and has held it in 3 quarters since. The position peaked at $160K in Q1 2024. 42 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

  • Belvedere Trading held 761 shares of Cardlytics worth $3.42K as of Q2 2026.
  • Cardlytics was a new Belvedere Trading position in Q2 2026.
  • Cardlytics made up ﹤0.01% of Belvedere Trading's portfolio in Q2 2026, its #999 holding.
  • Belvedere Trading first reported a position in Cardlytics in Q2 2023 and has held it in 3 quarters since.
  • Belvedere Trading's Cardlytics position peaked at $160K in Q1 2024.
  • 42 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on Belvedere Trading's 13F filing for Q2 2026, filed 31 Jul 2026.